C3 shares up after TGA completes ReCell approval

Shares in biomedical company Clinical Cell Culture Ltd have surged over 7 per cent today after announcing the Therapeutic Goods Administration has completed its approval process of ReCell®, which has been placed on the Australian Register of Therapeutic Goods.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer